| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 36.307 | 69.853 | 66.863 | 26.200 | 62.394 | 125.916 | 184.588 | 238.069 |
| Total Income - EUR | - | 0 | 36.311 | 69.855 | 66.901 | 26.218 | 62.405 | 125.951 | 184.653 | 239.586 |
| Total Expenses - EUR | - | 89 | 15.680 | 7.920 | 7.156 | 6.597 | 9.342 | 9.688 | 11.201 | 35.417 |
| Gross Profit/Loss - EUR | - | -89 | 20.631 | 61.935 | 59.745 | 19.621 | 53.063 | 116.263 | 173.452 | 204.169 |
| Net Profit/Loss - EUR | - | -89 | 20.268 | 61.236 | 59.076 | 19.375 | 52.451 | 115.307 | 171.892 | 197.132 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Eds Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.095 | 6.313 | 5.514 | 8.695 | 8.291 | 11.865 | 11.153 | 10.372 | 121.506 |
| Current Assets | - | 13 | 14.658 | 56.650 | 53.083 | 12.441 | 56.544 | 108.950 | 163.394 | 159.151 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.085 |
| Receivables | - | 0 | 0 | 0 | 42.533 | 0 | 0 | 80.525 | 139.531 | 75.125 |
| Cash | - | 13 | 14.658 | 56.650 | 10.550 | 12.441 | 56.544 | 28.425 | 23.863 | 28.661 |
| Shareholders Funds | - | -45 | 20.224 | 61.279 | 60.248 | 19.425 | 52.500 | 115.356 | 171.858 | 197.181 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.693 | 747 | 884 | 1.529 | 1.306 | 15.910 | 4.747 | 1.908 | 80.336 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.487 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Eds Med S.r.l.